SLP SHAREHOLDER ALERT: Simulations Plus, Inc. Investors may have been Affected by Fraud -- Contact BFA Law about its Investigation

Core Insights - Simulations Plus, Inc. is under investigation for potential violations of federal securities laws following disappointing financial disclosures and issues with internal controls [1][3]. Company Overview - Simulations Plus is a software company focused on modeling and simulation tools for the pharmaceutical, biotechnology, and chemical industries [2]. Acquisition and Integration Issues - In June 2024, Simulations Plus acquired Pro-ficiency Holdings, Inc., claiming the acquisition would double its total addressable market and significantly contribute to sales [2][3]. - However, the company appears to have struggled with the integration of Pro-ficiency and lacked effective internal controls over financial reporting [3]. Financial Performance and Stock Impact - On June 11, 2025, Simulations Plus announced disappointing preliminary financial results for Q3 2025, attributing the decline to market uncertainties, leading to a stock price drop of over 24% [4]. - The company reported a $77.2 million charge related to prior acquisitions in its Q3 2025 results, and subsequently dismissed its auditor, Grant Thornton, due to unresolved issues regarding segment reporting and internal controls [5]. - Following these revelations, the stock price fell nearly 26% from $17.47 to $12.97 per share [5].